BBC News -- A new drug for skin cancer can slow the spread of the disease in half of patients, thereby extending their lives, a study says. A trial of 680 patients at the Royal Marsden Hospital, London tested a drug that attacks a genetic mutation found in half of all skin cancer cases.
